Where drug teams run their entire program, discovery to FDA approval
Enjamb runs the entire drug program for biopharma teams, from discovery to FDA approval. Pharma runs on decades of closed legacy systems like Benchling, Veeva, Medidata, and SAS, with no AI layer and no MCP to connect agents to them. So we built that connection layer in one platform. Our agents run on top of their existing systems and data, with no migration, and do the work across the whole program: clinical evidence, trial design, statistical programming, and regulatory submissions. In just 3 weeks since launch, we're already being used by 500+ employees at top pharma companies, including Johnson & Johnson, AbbVie, Bristol Myers Squibb, Merck & Sanofi.
Founder
Maadhav is an AI researcher. He was the youngest engineer at Dell's AI Lab, shipping AI CPU optimization on supercomputing infra,. He also worked at Broadcom R&D developing SOTA AI ASICs. For fun, he built a Rocket League AI trained on 1M+ sessions that beats the top 1% of players.
Founder
Rayan is an ML and biology researcher. At 17, he published a first-author cancer ML paper in JMIR that beat SOTA models by 20%. He researched drug-therapeutics for pesticide poisoning(30% more effective) and presented at top bio conferences (SOT, ISCB).
